J&J Faces New Challenge To Schizophrenia Drug
J&J filed the suit through its Belgium-based subsidiary Janssen Pharmaceutica NV and its New Jersey-based partners Janssen Pharmaceutical Products LP. The suit was filed in the U.S. District Court for the District of New Jersey.
The suit was triggered by Dr. Reddy’s January filing with the U.S. Food and Drug Administration of...
To view the full article, register now.